CME Insider Tierney Robert JR Buys $145K of Stock
Robert Tierney JR. bought 645 shares of CME Group Inc. for $145,125, reflecting a purchase price of $225 each.
Reviewed by automated data checks against the source filing. How we make and check alerts
Tierney Robert JR bought 645 shares of CME Group Inc. ($CME) at an average price of $225, worth about $145,125, on June 25, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $CME is up 5.2% after 1 week, up 13.5% after 1 month and up 31.2% to date (from the $223.95 close on Jun 25, 2026).
Key Points
- On June 25, 2026, Robert Tierney JR. purchased 645 shares of CME Group Inc. valued at $145,125, with each share priced at $225.
- CME Group shares closed at $218.58, just above the 52-week low of $218.31, indicating a potential opportunity for buyers.
- CME Group has a market cap of approximately $99.1 billion and a P/E ratio of 23.37, reflecting its robust standing in the financial services sector.
Get $CME trade alerts by text
We text you when insiders, Congress or big funds trade $CME. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures
Robert Tierney JR. bought 645 shares of CME Group Inc. (CME) for $145,125 on June 25, 2026. The shares were purchased at a price of $225 each. This transaction was detailed in the latest insider trading report.
Inside Tierney's Trade
Tierney's purchase adds to a growing trend of insider buying at CME Group. The total value of this transaction indicates confidence, especially as the shares are trading near their 52-week low. CME's stock closed at $218.58 on the publication date, which is just above its 52-week low of $218.31.
Other Institutional Activity in CME Group
In addition to Tierney's purchase, several institutional investors have adjusted their positions in CME Group. BlackRock Inc. reduced its holdings by 880,512 shares, ending with about 30.6 million shares valued at approximately $8.9 billion. Conversely, Vanguard Capital Management LLC added 294,430 shares, bringing its total to around 23.7 million shares worth about $6.9 billion. State Street Corporation increased its stake by 290,606 shares, totaling roughly 16.3 million shares valued at about $4.8 billion. Morgan Stanley also added 321,702 shares, reaching nearly 9.7 million shares valued at around $2.8 billion, while Geode Capital Management grew its holdings by 124,398 shares, for a total of about 9.3 million shares worth about $2.7 billion.
CME Group Inc. Stock Down 24.5%
CME Group shares are currently trading at $218.58, which is significantly below their 50-day moving average of $266.98 and their 200-day average of $278.70. The stock's performance indicates a decline from its 52-week high of $329.16, suggesting potential volatility in the near future.
Recent Earnings
In its latest earnings report, CME Group reported revenue of $6.76 billion and an EPS of $11.79. The company's net margin stood at approximately 63.4%, and it has a return on equity (ROE) of 15.8%. The next earnings date is scheduled for October 21, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target cuts vs 0 raises.
-
EPS & revenue
EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.
-
Profit surprise
EBITDA missed by 6 percent. Operating income missed by 5 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
2 target cuts.
-
Earnings quality
Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.
Earnings Call Summary
CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.
Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.
Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.
Dividend
CME Group pays an annual dividend of $5.20, which translates to a yield of 1.88%. The company has a payout ratio of approximately 95.4%, indicating a commitment to returning earnings to shareholders.
Insider Buying and Selling at CME Group Inc.
On June 25, 2026, several insiders also made purchases. Timothy Bitsberger bought 645 shares at $225 each, totaling $145,125. Daniel Kaye matched that with a purchase of 645 shares for the same total amount. Additionally, Ford Harold Eugene JR. bought 1,067 shares at the same price, bringing his total investment to $240,075. Patrick Maloney also bought 645 shares for $145,125. All these transactions were not planned.
Analysts Set New Price Targets
Analysts have been maintaining optimistic views on CME Group. On October 14, 2026, Wells Fargo maintained an Overweight rating with a new price target of $315, up from the previous target of $301. Morgan Stanley also kept its Overweight rating, raising its target to $337 from $330 on October 9, 2026. Other firms such as Barclays and UBS maintain their ratings with price targets of $281 and $270, respectively.
About CME Group
CME Group Inc. operates markets for trading futures and options contracts globally. Its offerings include products based on interest rates, equity indexes, foreign exchange, and various commodities. This strategic position makes CME a key player in the financial data and stock exchange industry.
Bottom Line
Investors should keep an eye on CME Group as it approaches its next earnings date on October 21, 2026. The recent insider buying reflects confidence in the company's performance, while continued institutional trading could influence stock price movements. Remember, the filings like Tierney's reflect past positions and may not indicate current strategies.
Source: Tierney Robert JR's Form 4 filing on $CME (Jun 25, 2026). Find the original filing: CME Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
